NYSE:DVAHealthcare
Is It Too Late To Consider DaVita (DVA) After A 70% Year To Date Surge?
Investors may be wondering whether DaVita's share price still offers value after a strong run, or if most of the opportunity has already been priced in.
The stock closed at US$194.61, with returns of 31.6% over the past month, 70.0% year to date and 33.5% over the past year. This naturally raises questions about growth potential and changes in perceived risk.
Recent attention on DaVita has focused on how investors view the resilience of its dialysis business model and the long term demand...